Lexicon Pharmaceuticals
LXRX
#6851
Rank
โ‚ฌ0.66 B
Marketcap
1,50ย โ‚ฌ
Share price
-4.55%
Change (1 day)
16.74%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total assets

Total assets on the balance sheet as of June 2026 : โ‚ฌ0.22 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total assets are โ‚ฌ0.22 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lexicon Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ0.15 B-45.09%
2024-12-31โ‚ฌ0.28 B38.18%
2023-12-31โ‚ฌ0.20 B14.58%
2022-12-31โ‚ฌ0.18 B49.83%
2021-12-31โ‚ฌ0.12 B-27.03%
2020-12-31โ‚ฌ0.16 B-55.57%
2019-12-31โ‚ฌ0.37 B50.13%
2018-12-31โ‚ฌ0.24 B-31.73%
2017-12-31โ‚ฌ0.36 B-19.54%
2016-12-31โ‚ฌ0.45 B-24.17%
2015-12-31โ‚ฌ0.59 B53.84%
2014-12-31โ‚ฌ0.38 B95.23%
2013-12-31โ‚ฌ0.19 B-29.37%
2012-12-31โ‚ฌ0.28 B-15.22%
2011-12-31โ‚ฌ0.33 B20.19%
2010-12-31โ‚ฌ0.27 B53.31%
2009-12-31โ‚ฌ0.17 B-3.82%
2008-12-31โ‚ฌ0.18 B-26.04%
2007-12-31โ‚ฌ0.25 B75.4%
2006-12-31โ‚ฌ0.14 B-21.9%
2005-12-31โ‚ฌ0.18 B18.15%
2004-12-31โ‚ฌ0.15 B-30.77%
2003-12-31โ‚ฌ0.22 B16.95%
2002-12-31โ‚ฌ0.19 B-28.97%
2001-12-31โ‚ฌ0.27 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Thermo Fisher Scientific
TMO
โ‚ฌ100.99 B 45,158.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ5.85 B 2,522.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ37.24 B 16,588.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚ฌ1.12 B 405.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ1.95 B 774.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ0.41 B 84.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.33 B 50.20%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ10.46 B 4,588.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ5.63 M-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA